QUELLIS BIOSCIENCES, INC.

Profile

Company Names

QUELLIS BIOSCIENCES, INC.

Addresses

203 CRESCENT STREET, BLDG. #17, SUITE #102B, WALTHAM, MA 02453

2001 MARKET STREET, SUITE 2500, PHILADELPHIA, PA 19103

Phone Numbers

919-949-8552
267-760-4066

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$12,068,212.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-12-14 
$0.00 
$1,021,981.00 
$1,021,981.00 
 
2
2018-11-27 
$12,068,212.00 
$18,519,814.00 
$6,451,602.00 
Equity, Debt 
1
2018-05-21 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED 
 
CALLORI 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  CATABASIS PHARMACEUTICALS INC   |  NEPHRODI THERAPEUTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  ZUCARA THERAPEUTICS INC.
FREDERICK 
 
CALLORI 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  CEREVASC, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  JUNO DIAGNOSTICS, INC.   |  POLYCORE THERAPEUTICS, INC.
CHRIS 
 
GARABEDIAN 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  VYOME THERAPEUTICS INC.   |  CEREVASC, INC.   |  NEPHRODI THERAPEUTICS, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  SHIFA BIOMEDICAL CORP   |  JUNO DIAGNOSTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  POLYCORE THERAPEUTICS, INC.   |  VIVOSENSE, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  MAREA THERAPEUTICS, INC.   |  ZUCARA THERAPEUTICS INC.
CHRISTOPHER 
 
GARABEDIAN 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  LANDOS BIOPHARMA, INC.
PETER 
 
HARWIN 
EXECUTIVE OFFICER, DIRECTOR
FAIRMOUNT HEALTHCARE FEEDER FUND LTD.   |  FAIRMOUNT HEALTHCARE FUND L.P.   |  QUELLIS BIOSCIENCES, INC.   |  VIRIDIAN, LLC   |  FAIRMOUNT HEALTHCARE FEEDER FUND II LTD.   |  FAIRMOUNT HEALTHCARE FUND II L.P.   |  VIRIDIAN THERAPEUTICS, INC.   |  UNUM THERAPEUTICS INC.   |  PARAGON THERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE CO-INVEST L.P.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE FEEDER FUND II L.P.   |  FAIRMOUNT HEALTHCARE CO-INVEST II L.P.   |  SPYRE THERAPEUTICS, INC.   |  GALECTO, INC.
TOMAS 
 
KISELAK 
EXECUTIVE OFFICER, DIRECTOR
FAIRMOUNT HEALTHCARE FEEDER FUND LTD.   |  FAIRMOUNT HEALTHCARE FUND L.P.   |  QUELLIS BIOSCIENCES, INC.   |  VIRIDIAN, LLC   |  FAIRMOUNT HEALTHCARE FEEDER FUND II LTD.   |  FAIRMOUNT HEALTHCARE FUND II L.P.   |  VIRIDIAN THERAPEUTICS, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  FAIRMOUNT HEALTHCARE CO-INVEST L.P.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE FEEDER FUND II L.P.   |  FAIRMOUNT HEALTHCARE CO-INVEST II L.P.   |  SPYRE THERAPEUTICS, INC.   |  ZENAS BIOPHARMA, INC.
JONATHAN 
 
VIOLIN 
EXECUTIVE OFFICER, DIRECTOR
VIRIDIAN, LLC   |  DIANTHUS THERAPEUTICS, INC.   |  VIRIDIAN THERAPEUTICS, INC.   |  QUELLIS BIOSCIENCES, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  CATABASIS PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-12-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-12-14 
2020-08-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-11-27 
2018-12-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-11-27 
2018-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#